Results 131 to 140 of about 254,202 (199)

Influence of community disadvantage on cognitive performance in son-mother dyads in Duchenne muscular dystrophy. [PDF]

Brain Commun
Karra H, Penumalee VS, Arun S, Javalkar S, Bibat G, Ridder M, Kaat AJ, Thangarajh M.   +7 more
europepmc   +1 more source

Pharmacotherapy of Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy (DMD) is a severe, progressive neuromuscular disorder caused by mutations in the DMD gene, leading to the absence of functional dystrophin protein.
Poornachandran, Deepti Nirja
core  

Dynamic changes in total hemoglobin concentration in the frontal region during motion-based video gameplay in patients with Duchenne muscular dystrophy: a pilot study using portable near-infrared spectroscopy (NIRS). [PDF]

BMC Res Notes
Okano S, Mori S, Nishizawa H.
europepmc   +1 more source

Basal Energetics and Phosphocreatine Recovery Kinetics in Ambulatory Boys With Duchenne Muscular Dystrophy. [PDF]

NMR Biomed
Awale PP, Lopez C, Taivassalo T, Vandenborne K, Walter GA, Forbes SC.   +5 more
europepmc   +1 more source

Current and prospective treatment of Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a serious condition of genetic origin that is passed down in the X-linked manner and that mainly afflicts boys. It is the result of a steady muscle tissue degeneration caused by mutations in the dystrophin gene on the
Rodriguez, Isaac
core  

Role of Finerenone in Duchenne Muscular Dystrophy in a 45-Year-Old Man: Outcome and Brief Review. [PDF]

JACC Case Rep
Hillyer J, Jefferies JL, Silver MA.
europepmc   +1 more source

Adrenal insufficiency in individuals with Duchenne muscular dystrophy treated with glucocorticoids: Insights from the past, current challenges, and future directions. [PDF]

J Neuromuscul Dis
Weber DR, Ahmet A, Kinnett K, Lautatzis ME, McMillan HJ, Apkon S, Bansal S, Benjamin RW, Clemens PR, Crane JL, Fiscaletti M, Lam C, McAdam L, Rutter MM, Merchant N, Nasomyont N, Nicolau S, Phung K, Renthal N, Scavina M, Sorbara J, Tamaroff J, Tian C, Wood C, Aversa T, Bello L, Corbetta S, Cumbo F, De Sanctis L, Di Iorgi N, Ferlin A, Fintini D, Mercuri EM, Panicucci C, Tornese G, Schrader R, Selby KA, Veerapandiyan A, Wong SC, Ward LM, Sbrocchi AM.   +40 more
europepmc   +1 more source

Development and Validation of a Novel, Disease-Specific, Caregiver-Reported Outcome Measure: The Duchenne Muscular Dystrophy Caregiver Reported-Health Index (DMDCR-HI). [PDF]

Muscle Nerve
Engebrecht C, Rosero S, Weinstein J, Seabury J, Varma A, Zizzi C, Heatwole J, Dilek N, Kaat A, Guntrum D, Ciafaloni E, Heatwole C.   +11 more
europepmc   +1 more source

Emerging Therapies in Duchenne Muscular Dystrophy: A Comparative Analysis of Gene Therapy and Pharmacological Approaches

Duchenne muscular dystrophy (DMD) is a progressive and severe X-linked recessive disorder characterized by progressive muscle weakness due to degeneration of muscle fibers resulting in a shortened life span.
Ninsiima , Karen Tukahirwa Jessica
core  

Functional assessments used in routine care for duchenne muscular dystrophy in the United States: A survey of certified duchenne care centers. [PDF]

J Neuromuscul Dis
Duvuru R, Camino E, Schrader R, Freed M, Signorovitch J, Zhong J, Bi S, Ward SJ, Veerapandiyan A.   +8 more
europepmc   +1 more source